High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It plans to enroll 294 participants.

Also called NCT02534155

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 294 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02534155
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany, Italy, Switzerland (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02534155. Randomized; no masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy
Acronym
HiRiDe
Condition
Mitral Valve Insufficiency
Intervention (Device)
MitraClip®
Intervention (Procedure)
Mitral valve Surgery
Lead sponsor
University of Zurich (class: other)

Record details

Record id
cardio:ct-nct02534155
Content hash
da17f06cb03abf7c940d9596b55a5a407fb03a027d57bd30c3ab7768783fab13